Loading...
NPI 1568724243 · Scott, LA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Premier Laboratory Services, LLC is a clinical medical laboratory provider located in Scott, Louisiana. This profile covers 60 Medicare and 163 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Premier Laboratory Services, LLC |
| Address | 105 Park West Dr |
| City | Scott |
| State | LA |
| ZIP | 70583 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | June 8, 2012 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $26.7M |
| Medicare | $183.8K |
This entity is heavily Medicaid-dominant: lifetime Medicaid revenue is $26.7M versus total Medicare revenue of $183.8K, indicating that the provider’s commercial/payer exposure for this profile is overwhelmingly through Medicaid rather than Medicare. The absolute scale difference suggests the lab’s operational focus and negotiating leverage are concentrated on state Medicaid channels.
Revenue concentration differs sharply by payer: the provider’s top three Medicare codes account for 37.4% of its Medicare revenue, while the top three Medicaid codes account for 61.1% of its Medicaid revenue. This shows a relatively diversified Medicare mix by code but a high dependence on a few high-volume tests in Medicaid, increasing revenue sensitivity to coverage and reimbursement changes for those specific codes.
Medicaid code mix and volumes indicate a high-throughput molecular and toxicology operation: U0003 appears at 165.6K claims and $5.5M revenue and 0202U appears at 14.9K claims and $5.4M revenue, while G0481 generated $2.6M from 34.9K claims. These volumes and the PLA status of 0202U point to large-scale SARS–CoV–2 and multiplex respiratory panel testing alongside significant definitive drug-testing capacity supporting statewide testing programs.
On the Medicare side the mix is more typical clinical laboratory work: U0003 accounts for $33.7K (20.5% of the provider’s Medicare revenue) while routine panels such as 80053 (1.4K claims, $14.2K revenue) and 85025 (1.7K claims, $13.8K revenue) are prominent. That mix suggests the lab also provides standard ambulatory chemistry and hematology services to Medicare beneficiaries in addition to molecular testing.
Competitive standing is strong in-state for specific Medicaid codes: 0202U ranks #1 of 60 providers in-state (100th percentile; extreme outlier, far above typical state volume) and U0003 ranks #3 of 97 (98th percentile; notably above typical state volume). The provider also holds numerous #1 in-state positions on toxicology codes (for example 80348, 80373, 80370, 80323, 80347 each listed as #1 of their peer sets), indicating a leadership role within Louisiana Medicaid for both respiratory-panel PLA testing and broad toxicology services.
By contrast, the provider’s national Medicare footprint is modest: U0003 ranks #275 of 973 providers nationally (72th percentile) and common panels such as 80053 and 85025 show high percentile placements among large national pools but correspond to only $183.8K total Medicare revenue. Taken together, the data indicate the lab is not a major national Medicare player despite relatively high percentile ranks on a few routine codes, because the overall Medicare revenue base is small.
Several Medicaid signals are flagged as statistical outliers or notably above typical volume, which is meaningful operationally: 0202U is described as an extreme outlier, far above typical state volume, and multiple 803xx drug-testing codes are flagged as notably above typical state volume or extreme outliers. For payers and network managers, these descriptors imply concentrated processing capacity for proprietary respiratory panels and extensive toxicology throughput that may drive state-level utilization patterns.
The provider has an established operating history, with the NPI enumerated on 2012-06-08 (~14 years ago), supporting that the high Medicaid volumes reflect sustained capacity rather than a very recent ramp-up. Given the Medicaid concentration and the provider’s statewide leadership on selected PLA and toxicology codes, payers should treat this entity as a Medicaid-focused, high-throughput lab partner when evaluating network access and utilization controls.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
60 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 460 | $70 | $33.7K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 1,420 | $10 | $14.2K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 1,720 | $10 | $13.8K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 1,060 | $10 | $13.7K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 830 | $20 | $13.3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 460 | $30 | $11.4K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 390 | $30 | $11.2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 90 | $110 | $10.5K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 100 | $60 | $6.2K |
| 84439 | The lab analyst performs a test to measure free thyroxine, or free T4, typically in patient serum. | 480 | $10 | $4.3K |
Showing 1–10 of 60
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 60 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
163 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 165,580 | $30 | $5.5M |
| 0202U | This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0202U for the… | 14,910 | $360 | $5.4M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 34,850 | $70 | $2.6M |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 11,630 | $120 | $1.4M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 41,680 | $30 | $1.4M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 138,520 | $10 | $1.2M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 26,290 | $30 | $657.1K |
| 80348 | The lab analyst measures the amount of or detects the presence of buprenorphine in a patient specimen. Buprenorphine is a drug used to treat opioid addiction, to control acute pain in individuals who… | 24,590 | $10 | $270.5K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 15,900 | $20 | $254.3K |
| 80373 | The lab analyst measures the amount of or detects the presence of tramadol, which is a centrally acting opioid pain medication, in the patient specimen. | 24,900 | $10 | $249K |
Showing 1–10 of 163
How this provider's Medicaid billing volume and revenue compare to other Louisiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Louisiana median
163 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 5 | 70 | 620 | $230 | $913.4K |
| 0202U | This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0202U for the… | 1 | 60 | 1,160 | $280 | $690.6K |
| 87541 | The lab analyst performs a test for the bacteria Legionella pneumophila using amplified nucleic acid probe technique. L. pneumophila can inhabit facility water and air conditioning systems and may… | 10 | 10 | 350 | $20 | $668.7K |
| 87507 | The lab analyst performs a test to detect 12 to 25 types or subtypes of a pathogen, such as Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia, that affects the gastrointestinal… | 4 | 10 | 210 | $280 | $667.5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 3 | 100 | 620 | $40 | $560K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3 | 30 | 1,340 | $60 | $499.3K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 8 | 90 | 650 | $40 | $404.2K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 20 | 20 | 690 | $20 | $359.2K |
| 87502 | The lab analyst performs a test to determine the presence of multiple types or subtypes of influenza virus through nucleic acid detection using multiplex amplified probe technique and possibly… | 146 | 210 | 630 | $70 | $239.6K |
| 84234 | The lab analyst performs a progesterone receptor assay, PRA, on tissue from a tumor, typically from the breast, to analyze for the presence of progesterone receptors, molecules that bind to the… | 1 | 10 | 5,100 | $40 | $221.3K |
Showing 1–10 of 163
Other providers in the same ZIP code as Premier Laboratory Services, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Therapy Center Of Acadiana | LA | Behavior Analyst | $0 | $6.3M |
| Susan Miedecke | LA | Family Nurse Practitioner | $74.5K | $0 |
| Institutional Pharmacies Of Louisiana L L C | LA | Institutional Pharmacy | $59.5K | $0 |
| Bradley Katt | LA | Physical Therapist | $33.3K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.